viewFinablr PLC

Finablr shares rally as JP Morgan and Barclays talk up Travelex owner

Finablr shares have fallen 24% since floating last month and its B2B payment technology business is being valued at around a 75% discount to the wider peer group, JP Morgan said

Finablr's three business lines include B2B payments and consumer currency exchange

Shares in Travelex owner Finablr PLC (LON:FIN) moved higher on Tuesday as JPMorgan Cazenove and Barclays began coverage of the UAE-based payments and bureau de change group. 

When it floated in May, Finablr was forced to slash the pricing of its offer to 174p per share from the initial 210p-260p range at a cut-price, and, not helped by a modest trading update for Travelex, has since seen its shares sink below 135p this month. 

READ: Travelex owner Finablr considers London float after strong demand for Network International IPO

But analysts at both banks saw value in the triple offer of B2B payment technology, consumer cross-border payments and bureau de change shops, with Cazenove setting a share price target of 190p and an ‘overweight’ rating, while Barclays set its target at 170p with an ‘equal weight’ rating. 

Cazenove, which was a sponsor on the IPO, said that Finablr’s payments and FX platform is underpinned by scalable proprietary technology that “provides a competitive advantage that would take a significant period to replicate” and offers the company the capacity to manage three times its current volumes. 

Caz estimates compound annual growth of underlying earnings (EBITDA) of 19% for the period from 2018 to 2021.

At the current share price, Finablr’s fast-growing B2B payment technology business is valued at around a 75% discount to the wider peer group, Cazenove said and the group's valuation “presents attractive risk-reward”.

Barclays calls for patience

Similarly Barclays, which was a joint co-ordinator on the IPO, sees lots to like from Finablr differentiating its offer from peers through its extensive pay-in and pay-out network, licences, technology and the strong consumer brands it owns, which has resulted in large tech businesses increasingly using its services. 

With the company guiding to high single-digit revenue growth with EBITDA margin approaching 20% over the medium term, implying high-teens EBITDA growth, Barclays valuation is based on a 12-time 2020 earnings per share “and implying fundamental valuation upside”. 

“However, we expect it will take time and a number of positive data points for the market to attribute fair value to the stock,” analysts added, with a likely second-half weighting and a continued lack of clarity around Brexit.

Finablr shares were up almost 3% to 145p on Tuesday morning.

Quick facts: Finablr PLC

Price: 214.2 GBX

Market: LSE
Market Cap: £15.05 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Futura Medical sees 'potentially quicker route to market' for its erectile...

Futura Medical PLC's (LON:FUM) executive director and head of R&D Ken James speaks to Proactive London's Andrew Scott following the read-out from the phase III clinical trial of its erectile dysfunction gel. James says while MED2005 showed strong efficacy, excellent safety and rapid speed...

53 minutes ago

2 min read